The Effect of Liraglutide on the GIT

Summary

Liraglutide is a glucose-like peptide 1 agonist, currently used as an effective weight-loss treatment. Its mechanism of action has not yet been elucidated. We want to investigate whether liraglutide affects MMC activity, gastrointestinal hormone release, glucose whole blood levels, hunger ratings and ad libitum food intake in healthy volunteers.

Timeline

Start

2020-04-01

Primary completion

2021-04-01

Completion

2021-04-01

Drugs

Indications